(Q54389429)

English

Tumor heterogeneity revealed by KRAS, BRAF, and PIK3CA pyrosequencing: KRAS and PIK3CA intratumor mutation profile differences and their therapeutic implications.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24352906

Tumor heterogeneity revealed by KRAS, BRAF, and PIK3CA pyrosequencing: KRAS and PIK3CA intratumor mutation profile differences and their therapeutic implications. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24352906

1 reference

based on heuristic

inferred from title

author name string

Vivian Kosmidou

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24352906

Eftychia Oikonomou

2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24352906

Margarita Vlassi

3

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24352906

Spyros Avlonitis

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24352906

Anastasia Katseli

5

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24352906

Iraklis Tsipras

6

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24352906

Despina Mourtzoukou

7

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24352906

Georgios Kontogeorgos

8

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24352906

Georgios Zografos

9

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24352906

Alexander Pintzas

10

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24352906

publication date

15 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24352906

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24352906

35

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24352906

3

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24352906

329-340

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24352906

Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Combined mutational analysis of KRAS, NRAS and BRAF genes in Indian patients with colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

PIK3CA cancer mutations display gender and tissue specificity patterns.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Detection of KRAS mutations in colorectal carcinoma patients with an integrated PCR/sequencing and real-time PCR approach.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Computational analysis of KRAS mutations: implications for different effects on the KRAS p.G12D and p.G13D mutations

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

EGFR and colon cancer: a clinical view.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Recurrent KRAS codon 146 mutations in human colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Targeting PI3K signalling in cancer: opportunities, challenges and limitations

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

A genetic model for colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Molecular circuits of solid tumors: prognostic and predictive tools for bedside use.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

The frequency of KRAS mutation detection in human colon carcinoma is influenced by the sensitivity of assay methodology: a comparison between direct sequencing and real-time PCR.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

The use of COLD-PCR and high-resolution melting analysis improves the limit of detection of KRAS and BRAF mutations in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

KRAS p.G13D mutations are associated with sensitivity to anti-EGFR antibody treatment in colorectal cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Aspirin use and risk of colorectal cancer according to BRAF mutation status

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Sensitive sequencing method for KRAS mutation detection by Pyrosequencing

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Many different tumor types have polyclonal tumor origin: evidence and implications.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

PIK3CA mutations are not a major determinant of resistance to the epidermal growth factor receptor inhibitor cetuximab in metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Novel mutant-enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Intra-tumoral heterogeneity of KRAS and BRAF mutation status in patients with advanced colorectal cancer (aCRC) and cost-effectiveness of multiple sample testing.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

High frequency of mutations of the PIK3CA gene in human cancers

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

The epidermal growth factor receptor pathway: a model for targeted therapy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Absence of tyrosine kinase mutations in Japanese colorectal cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

PIK3CA is implicated as an oncogene in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Intratumor heterogeneity: evolution through space and time

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

The prevalence of PIK3CA mutations in gastric and colon cancer.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Frequency and spectrum of K-RAS codons 12 and 13 mutations in colorectal adenocarcinomas from Taiwan.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Pyrosequencing cut-off value identifying BRAFV600E mutation in fine needle aspiration samples of thyroid nodules.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Stem cells and their implications for colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Clonality Assessment and Clonal Ordering of Individual Neoplastic Crypts Shows Polyclonality of Colorectal Adenomas

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

21 January 2018

Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

PIK3CA mutation is predictive of poor survival in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Patient with colorectal cancer with heterogeneous KRAS molecular status responding to cetuximab-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns ofPIK3CA alterations in familial colorectal and endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Poor Survival Associated with theBRAFV600E Mutation in Microsatellite-Stable Colon Cancers

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Oncogenic mutations of PIK3CA in human cancers

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22496

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HUMU.22496

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24352906

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24352906

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54389429&oldid=1795916106"